Calcineurin-immunosuppressor complexes

Current Opinion in Structural Biology

Volumn 6, Issue 6, 1996, Pages 770-775

  Stoddard, Barry L ^a   Flickt, Karen E ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; IMMUNOPHILIN; IMMUNOSUPPRESSIVE AGENT; PHOSPHATASE; TACROLIMUS;

COMPLEX FORMATION; CRYSTAL STRUCTURE; DRUG PROTEIN BINDING; ENZYME CONFORMATION; ENZYME INHIBITION; PRIORITY JOURNAL; SHORT SURVEY; X RAY CRYSTALLOGRAPHY;

EID: 0030444584     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-440X(96)80006-6     Document Type: Article

References (39)

1. Williams DH, Stone MJ, Hauck PR, Rahman SK: Why are secondary metabolite(natural products) biosynthesized? J Nat Prod 1989, 52:1189-1208
2. Bierer BE, Manila PS, Standaert RR Herzenberg LA, Burakoff SJ, Crabtree G, Schreiber SL: Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. Proc Natl Acad Sci USA 1990, 87:9231-9235.
3. Handschurnacher RE, Harding MW, Rice J, Drugge RJ: Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science 1984, 226:544-547.
4. Tropschug M, Barthelmess IB, Neupert W: Sensitiwity to cyslosporin A is mediated by cyclophilin in Neurospora crassa and Secc/iaromyces cerevisiae. Nature 1 989, 342:953-955.
5. Heitman J, Vovva NR, Hiestand PC, Hall MN: The FK506binding protein proline roiamase is a target for the immunosuppressive agent FK50B in Saccharomyces cererisiae, Proc Nat! Acad Sei USA 1 991, 88:1948-1952.
6. Kollin Y, Faucette L, Bergsma DJ, Levy MA, Cafferkey R, Koser PL, Johnson RK, Levi GP: Rapamycin sensitivity in Saccharomyces cerewsi'ae is mediated by a peplidyl-prolyl cis-trans isomerase related to human FK506-binding protein. Mo! Cell Bio! 1991, 11:1718-1723.
7. Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman l, Schreiber SL: Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991, 56:807-815.
8. O'Keefe SJ, Tamura J, Kmcaid RL, TDCCI MJ and O'Neill EA: FK506 and CsA-sensitwe activation of the interleukin-2 promoter by calcineurin. Nature 199S, 357:692-694.
9. Clipstons NA and Crabtree GR: Identification of calcineurin as a key signaling enzyme in T-lymphocvte activation. Nature 1992, 357:695-697.
10. Wattila PS, Ulman KS, Bering S, Emmel EA, McCutcheon M, Crabtree GR, Herzenberg LA: The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes. EM8O J 1990, 9:4425-4433
11. Emmel EA, Verweij CL, Durand DB, Higgins KM, Lacy E, Crabtree G: Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation. Science 1989, 246:1617-1620.
12. Randak C, Brablelz T, Hergenrother M, Sobotta I, Serfling E: Cyclosporin A suppresses the expression of the interleukin 2 gene by inhibiting the binding of lymphocyte-specific factors to the IL-2 enhancer. EMBO J 1990, 9:2529-2536.
13. Ranagan WM, Corthesy B, Bram RJ, Crabtree GR: Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 1991, 352:803-807.
14. llo A, Hashimolo T, Hirai M, Takeda T, Shuntah H, Kuno T, Tanaka C: The complete primary structure of calcineurin A, a calmodulin binding protein homologous with protein phosphatases 1 and 2A. Biochem Biophys Res Commun 19B9, 163:1492-1497.
15. Cohen PTW; Two isoforms of protein phosphatase 1 may be produced from the same gene, FEBS Let! 1988, 232:17-23,
16. Klee CB, Crouch TH and Krinks MH: Calcineurin: a calcium- and calmodulin binding protein of the nervous system. Proc Nstl Acad Sei USA 1979, 76:B270-B273.
17. Hashimolo Y, Perrino BA, Soderling TR: Identification of an autoinhibitory domain in calcineurin. J Bio! Chem 1990, 265:1924-1927.
18. Watanabe Y, PerrinU BA, Chang BH, Soderfing TR; Identification in the calcineurin A subunit of the domain that binds the regulatory B suburit J Biol Chsm 1995, 270:456-460
19. Slemmer PM, Klee CB: Dual calcium ion regulation of calcineurin by calmodulin and calcineurin B. Biochemistry 1994, 33:6859-6866.
20. Griffith JR Kim JL, Kim EE, Sinlchak WD, Thomson JA, Fiubiggori MJ, Fleming MA, Caron PR, Hsiao K, Navia MA: X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex. Ce/M995, 82:507-522. The X-ray structure ol the ternary complex of a bovine calcineurin CaNA fragment (missing the CaM binding region and autoinhibrtory region), CaNB, FKBP12, and the immunosuppressant drug FK506 at 2.5A resolution is presented. The authors hypothesize that binding of the immunophilin-immunosuppressant complex inhibits the dephosphorylation activity ol calcineurin by physically hindering the approach of protein substrates to the active site.
21. Kissinger CR, Parge HE, Knighlon DR, Lewis CT, Pelletier LA, Tempczyk A, Kalish VJ, Tucker KD, Showalter RE, Moomaw EW et al.: Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex. Nature 1995, 378:641-644. The X-ray structures of full-length human calcineurin at 2 1 A resolution and the human calcineurin complex with FKBP12/FK5Q6 at 3.5A resolution are presented. Some additional details regarding the structural role of the autoinhibitory domain and the N-terminal region of the protein are provided by the complex; structure. The authors hypothesize that the inhibitory properties of the immunophilin-immunosuppressant complex may be due to long distance dynamic or structural effects imposed on the active site residues of the enzyme, in addition to indirect physical hindrance ol substrate binding.
22. Qoldberg J, Huang H-B, Kwon Y-G, Greengard P, Nairn AC, Kuriyan J: Three-dimensional structure of the catalytic subunit of protein serine/threonine phosphatase-1. Nature 1995, 376:745-753. The X ray structures of mammalian protein phosphatase 1 at 2.1 A resolution, complexed with the toxin microcystin, is presented. The fold oi the catalytic domain and the architecture of the active site side-chain network is closely preserved in calcineurin.
23. Strater N, Klabunde T, Tucker P, WiUel H, Krebs B: Crystal structure of a purple acid phosphatase containing a dinuclear Fe (Ill)-Zn (II) active site. Science 1995, 268:1489-1492. The first structure of a bimetallic SerrThr protein phosphatase is reported at 2.9 Aresolution. The coordination and identity ot the metal-ion cotactors serve as the initial model for the active sites of calcineurin reported in [20"] and [21 "]. The authors' hypothesis of a mechanism for phosphate ester hydrolysis involving nucleophilic attack by an iron-coordinated hydronide ion is supported by the subsequent structural studies ol PP1 and calcineurin.
24. EgloH MP, Cohen PTW, Reinemer P, Barford D: Crystal structure ol the catalytic subunit of human protein phosphatase 1 and its complex with tungstate, J Mo! Bio! 1995, 264:942-959. The structure of PPt-A in its active conformation is presented The structure was solved on the based of multiwavelength anomalous diffraction phasing from a tungstate molecule bound at the catalytic site. The nature of the metal was definitively established by protein induced X ray emission spectroscopy.
25. Oefner C, Suck D: Crystallographic refinement and structure of DNase I at 2 Aresolution. J Mol Biol 1986, 192:605-632.
26. Mol CD, Kuo CF, Thayer MM, Cunningham RP, Tamer JA: Structure and function of the multifunctional DNA-repair enzyme exonuclease III. Nature 1995, 374:381-386.
27. Meador WE, Means_AR, Uuiocho RA: Target enzyme recognition by calmodulin: 2.4 Astructure of a calmodulin-peptide complex. Science 1992, 257:1251 -1255,
28. Van Duyne GO, Standaert RF, Karplus PA, Schreiber SL, Clardy J: Atomic structure of FKBP-FK506. an immunophilin-irnmunosuppressant complex. Science 1991. 252:839-842.
29. Becker JW, Rotonda J, McKeever BM, Chan HK, Marcy AI. Wiederrecht G, Hermes JD, Springer JP; FK-506-binding protein: three-dimensional structure of the complex with the antagonist 1-685,813. J 3iu! Chem 1993, 268:11335-11339
30. Wilson KP, Yamashila MM. Sintchak MD, Rotstein SH, Murcko MA, Boger J, Thomson JA, Fitzgibbon WJ, Black JR, Navia MA: Comparative X-ray structures of the major binding protein for the immunosuppressant FK506 (tacrolimus) in unliganded form and in complex with FK606 and rapamycin. Acta Cfystatlogr D 1995, 51:511 - 521.
31. Aldape RA, Futer O, DeCenzo MT, Jarrett BP, Murcko MA. Livingston DJ: Charged surface residues of FKBP12 participate in formation of the FKBP12-FK506-calcineurin complex. J Bio! Chem 1992, 267:16029-16032.
32. Yang D, Rosen M K and Schreiber SL: A composite FKBP12-FK506 surface that contacts calcineurin. J Am Chem Soc 1993, 115:819-820
33. Fuler O, DeCenzo MT, Aldape RA, Livingston DJ: FK506 binding protein mutational analysis. J Bioi C/iem 1995, 270:18935-18940.
34. Parsons JN, Wiederrecht GJ, Salowe S, Kincaid RL, O'Keefe SJ: Regulation of calcineurin phosphatase activity and interactions with the FK506-FK506-binding protein complex, J Bio! Chem 1994, 269:19610-19616.
35. Lewis G, Gastinel L, Habuka N, Tucker K, Chen X, Maldonado F, Villafranca JE: Characterization of human recombinant calcineurin heterodimer co-expressed in bacteria and insect cells [abstract], FASEB J 1995, 9:1346.
36. Choi J, Chen J, Schreiber SL, Clardy SL: Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP Science 199B, 273:239-242. The crystal structure of the ternary complex of human FKBP12, rapamycin, and Ihe FKBP-rapamycm binding domain ot human FRAP (FKBP-rapamycin-associated protein) al 2.7A resolution reveals Ihe two proteins are bound together as a result of the ability of rapamycin to occupy two different hydrophobic binding pockets simultaneously.
37. Swanson SK, Born T, Zydowsky LD, Cho H, Chang HY, Walsh CT, Rusnak F: Cyclosporin-mediated inhibition of bovine calcineurin by cyclophilins A and B. Proe Nat! Acad Sei USA 1992, 69:3741-3745.
38. Coghlan VM, Perrino BA, Howard M, Langeberg LK, Hicks JB, Gallatin WM, Scott JD: Association of protein kinase A and protein phosphatease 2B with a common anchoring protein. Science 1995, 267:108-111.
39. Carson M: RIBBONS 2.0. J Appl Crystallogr 1991, 24:958-961.